Cargando…
Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines
Many studies have shown that the efficacy and risk of side effects of drug treatment is influenced by genetic variants. Evidence based guidelines are essential for implementing pharmacogenetic knowledge in daily clinical practice to optimize pharmacotherapy of individual patients. A literature searc...
Autores principales: | Abdullah-Koolmees, Heshu, van Keulen, Antonius M., Nijenhuis, Marga, Deneer, Vera H. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868558/ https://www.ncbi.nlm.nih.gov/pubmed/33568995 http://dx.doi.org/10.3389/fphar.2020.595219 |
Ejemplares similares
-
Pharmacogenomic information from CPIC and DPWG guidelines and its application on drug labels
por: Yoon, Deok Yong, et al.
Publicado: (2020) -
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines
por: Lunenburg, Carin A. T. C., et al.
Publicado: (2019) -
Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines
por: Manson, Lisanne E. N., et al.
Publicado: (2020) -
Pharmacogenes that demonstrate high association evidence according to CPIC, DPWG, and PharmGKB
por: Alshabeeb, Mohammad A., et al.
Publicado: (2022) -
Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC(®)) Guidelines and a Commercial Pharmacogenetics Laboratory in Genotype to Phenotype Interpretations For Patients Utilizing Psychotropics
por: Blazy, Christopher, et al.
Publicado: (2022)